-49.7%
INTU vs GSK
+31.2%
-80.9%
-63.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -1.9% | -1.4% | -3.7% |
| 7D | -7.1% | -1.8% | -5.3% | -7.3% |
| 30D | +1.5% | -2.2% | +3.6% | +1.1% |
| 3M | +10.7% | -1.8% | +12.5% | +10.5% |
| 6M | -23.8% | -10.6% | -13.2% | -24.8% |
| YTD | -49.3% | +4.4% | -53.7% | -49.8% |
| 1Y | -49.7% | +30.4% | -80.1% | -49.5% |
| All | -49.7% | +31.2% | -80.9% | -49.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling